Submit Manuscript  

Article Details


Biomarkers for Early Diagnosis of Acute Kidney Injury: Current Progress and Clinical Prospects

[ Vol. 18 , Issue. 12 ]

Author(s):

Hong-Feng Huang, Jing-Yi Zhou and Jiang-Hua Chen*   Pages 1205 - 1210 ( 6 )

Abstract:


Acute kidney injury (AKI) is one of the most common complications in critically ill patients, resulting in high morbidity and mortality. AKI usually occurs after major surgery, severe infection or drug-induced nephrotoxicity and is associated with prolonged hospital stays, increased costs and adverse clinical outcomes. The diagnosis of AKI is currently based on decreased glomerular filtration rate (GFR) and urine output, and increased serum creatinine. Novel biomarkers are required for early identification of patients with AKI to allow timely therapy and improve patient outcomes. With the advent of proteomics and genomics techniques, a vast array of biomarkers are now available in clinical practice.

Keywords:

Acute kidney injury, biomarkers, cystatin C, IL-18, KIM-1, L-FABP, NGAL, NHE-3.

Affiliation:

Kidney Disease Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Kidney Disease Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Kidney Disease Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Qingchun Road 79, Hangzhou

Graphical Abstract:



Read Full-Text article